Market revenue in 2022 | USD 3.6 million |
Market revenue in 2030 | USD 6.0 million |
Growth rate | 6.6% (CAGR from 2022 to 2030) |
Largest segment | Extracorporeal co2 machines |
Fastest growing segment | Other Products |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Extracorporeal CO2 machines, Disposables, Other Products |
Key market players worldwide | Medtronic PLC, Getinge AB ADR, Fresenius Medical Care AG, LivaNova PLC, Aferetica, Estor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to extracorporeal co2 removal devices market will help companies and investors design strategic landscapes.
Extracorporeal co2 machines was the largest segment with a revenue share of 52.78% in 2022. Horizon Databook has segmented the Canada extracorporeal co2 removal devices market based on extracorporeal co2 machines, disposables, other products covering the revenue growth of each sub-segment from 2017 to 2030.
Canada is one of the most developed and advanced economies in the world. It has a strong focus toward medical and healthcare infrastructure. As per 2011–2105 World Bank health expenditure, Canada spends nearly 10.4% of its GDP on healthcare. Moreover, increasing adoption of ECCO2R devices in hospitals, technological advancements in ECCO2R devices, and hospital care services are expected to boost market growth over the forecast period.
Moreover, increasing prevalence of diseases, such as respiratory failure and cardiopulmonary diseases, in the region accounts for significant market share of extracorporeal CO2 removal devices market. In addition, increasing healthcare innovations and rising awareness about ECCO2R machines is expected to increase investments by the Canadian government agencies in medical devices sector, which is further expected to boost demand for extracorporeal CO2 removal devices over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada extracorporeal co2 removal devices market, including forecasts for subscribers. This country databook contains high-level insights into Canada extracorporeal co2 removal devices market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account